ASEAN is home to more than 620 million people. As a group, it is enjoying robust economic growth. The strive towards the development of ASEAN free trade area (AFTA) will further stimulate economic integration and unleash the full potential of the people. Healthcare consumption is also growing in tandem with economic development. The demand for greater access to quality care is driving the growth of the market. The pharmamarket is expected to enjoy double digit growth over the next 5 years.

While the economy is integrating, the bloc of ten ASEAN nations is a hugely heterogeneous group. The difference in language, cultural heritage, political and social system has major impact on the way healthcare is delivered, and businesses are conducted. Without an in-depth understanding of the differences, it is easy to make fundamental errors of judgement. This is especially true in Sales & Marketing, an activity that relies largely on the success of building relationships.

Hyphens Pharma positions itself as a gateway to the Southeast Asia market. We function as a regionalSales & Marketing Organization (SMO) focusing on innovative human healthcare products with presence in six countries, and over 32 cities in the Asean region, Hyphens has in-depth knowledge and understanding ofASEAN’s similarity and diversity. This has enabled Hyphens to build strong business, regulatory, logistical and financial capabilities to move our brands into the markets. Every minute, 5.27 units of Hyphens Pharma's products are being sold in Southeast Asia.

We welcome our partners – medical professionals and biopharmaceutical industry partners alike to work with us and leverage on our extensive network in the region. It is through this partnership forged that we hope to provide a better quality of life for all.